Published in Am Heart J on January 01, 2011
Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol (2014) 0.86
Sex Differences in Outcomes Following Percutaneous Coronary Intervention According to Age. Circ Cardiovasc Qual Outcomes (2016) 0.84
The impact of gender on long-term mortality in patients with multivessel disease after primary percutaneous coronary intervention. Neth Heart J (2015) 0.83
Do gender differences in primary PCI mortality represent a different adherence to guideline recommended therapy? a multicenter observation. BMC Cardiovasc Disord (2014) 0.83
Comparison of clinical outcomes of Chinese men and women after coronary stenting for coronary artery disease: a multi-center retrospective analysis of 4,334 patients. J Biomed Res (2013) 0.79
The epidemiology and outcomes of percutaneous coronary intervention before high-risk noncardiac surgery in contemporary practice: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Registry. J Am Heart Assoc (2014) 0.79
Performance of reperfusion therapy and hospital mortality in ST-elevation myocardial infarction patients with non-chest pain complaints. Yonsei Med J (2014) 0.78
Sex-related differences in fractional flow reserve-guided treatment. Circ Cardiovasc Interv (2013) 0.77
Renal dysfunction in STEMI-patients undergoing primary angioplasty: higher prevalence but equal prognostic impact in female patients; an observational cohort study from the Belgian STEMI registry. BMC Nephrol (2013) 0.77
Gender Related Survival Differences in ST-Elevation Myocardial Infarction Patients Treated with Primary PCI. Int J Med Sci (2016) 0.75
Two-year clinical outcomes after coronary drug-eluting stent placement in Chinese men and women: a multicenter, prospective registry study. Patient Prefer Adherence (2013) 0.75
Factors affecting outcome of primary percutaneous coronary intervention for acute myocardial infarction. ARYA Atheroscler (2013) 0.75
Sex and Outcomes After Percutaneous Coronary Intervention: A Cause for Concern for Young Women and Those With ST-Segment Elevation Myocardial Infarction? J Am Heart Assoc (2017) 0.75
Gender-related differences in patients with ST-elevation myocardial infarction. Wien Klin Wochenschr (2015) 0.75
Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08
Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care. BMJ (2004) 3.99
Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med (2007) 3.92
Evaluation of advanced access in the national primary care collaborative. Br J Gen Pract (2004) 3.48
Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ (2007) 3.28
Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol (2008) 3.15
Public reporting and case selection for percutaneous coronary interventions: an analysis from two large multicenter percutaneous coronary intervention databases. J Am Coll Cardiol (2005) 3.01
Hospital complication rates with bariatric surgery in Michigan. JAMA (2010) 2.92
Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation (2004) 2.90
Predicting death in patients with acute type a aortic dissection. Circulation (2002) 2.68
Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol (2004) 2.68
Risk of acute kidney injury after percutaneous coronary interventions using radial versus femoral vascular access: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Circ Cardiovasc Interv (2014) 2.67
Long-term survival in patients presenting with type B acute aortic dissection: insights from the International Registry of Acute Aortic Dissection. Circulation (2006) 2.56
Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation (2010) 2.53
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol (2012) 2.53
Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol (2011) 2.50
Radiation dose from cardiac computed tomography before and after implementation of radiation dose-reduction techniques. JAMA (2009) 2.48
Clinical profiles and outcomes of acute type B aortic dissection in the current era: lessons from the International Registry of Aortic Dissection (IRAD). Circulation (2003) 2.32
Gender-related differences in acute aortic dissection. Circulation (2004) 2.24
How a regional collaborative of hospitals and physicians in Michigan cut costs and improved the quality of care. Health Aff (Millwood) (2011) 2.22
Comparative safety of vascular closure devices and manual closure among patients having percutaneous coronary intervention. Ann Intern Med (2013) 2.14
Operator experience and carotid stenting outcomes in Medicare beneficiaries. JAMA (2011) 2.12
Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation (2007) 2.12
Incorporating process utility into quality adjusted life years: a systematic review of empirical studies. Pharmacoeconomics (2013) 2.12
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation (2012) 2.08
Contemporary results of surgery in acute type A aortic dissection: The International Registry of Acute Aortic Dissection experience. J Thorac Cardiovasc Surg (2005) 2.08
Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventions. Circulation (2006) 2.07
Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv (2005) 2.00
Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol (2006) 2.00
From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J (2003) 1.94
Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med (2005) 1.92
Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation (2004) 1.77
Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study. Circ Res (2011) 1.77
The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med (2002) 1.76
Acute intramural hematoma of the aorta: a mystery in evolution. Circulation (2005) 1.76
The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv (2009) 1.75
The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity. Ann Surg (2013) 1.72
Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J (2008) 1.71
Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease. Circulation (2007) 1.68
Coronary computed tomography angiography after stress testing: results from a multicenter, statewide registry, ACIC (Advanced Cardiovascular Imaging Consortium). J Am Coll Cardiol (2012) 1.67
Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv (2009) 1.64
Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry. Catheter Cardiovasc Interv (2012) 1.62
The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention. J Am Coll Cardiol (2008) 1.62
Looking beyond historical patient outcomes to improve clinical models. Sci Transl Med (2012) 1.59
Long-term survival in patients presenting with type A acute aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation (2006) 1.57
Physician specialty and carotid stenting among elderly medicare beneficiaries in the United States. Arch Intern Med (2011) 1.49
Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute ST elevation MI: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord (2010) 1.48
Safety of transradial cardiac catheterization in patients with end-stage liver disease. Catheter Cardiovasc Interv (2013) 1.47
Effect of chronic kidney disease on outcomes after carotid artery stenting. Am J Cardiol (2004) 1.47
Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator. Am J Cardiol (2005) 1.45
Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol (2002) 1.45
Contemporary use of prasugrel in clinical practice: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Circ Cardiovasc Qual Outcomes (2013) 1.44
Chronobiological patterns of acute aortic dissection. Circulation (2002) 1.43
Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registry. JACC Cardiovasc Interv (2011) 1.42
Computer therapy compared with usual care for people with long-standing aphasia poststroke: a pilot randomized controlled trial. Stroke (2012) 1.40
Noninvasive thrombolysis using pulsed ultrasound cavitation therapy - histotripsy. Ultrasound Med Biol (2009) 1.39
Angiographic and clinical characteristics of type 1 versus type 2 perioperative myocardial infarction. Catheter Cardiovasc Interv (2013) 1.39
Impact of CMS coverage decision on access to transcatheter aortic valve replacement. Catheter Cardiovasc Interv (2014) 1.38
The role of clopidogrel in revascularized and nonrevascularized patients with acute coronary syndromes. Am J Cardiovasc Drugs (2007) 1.37
Cardiac surgeons and the quality movement: the Michigan experience. Semin Thorac Cardiovasc Surg (2009) 1.31
Noninvasive treatment of deep venous thrombosis using pulsed ultrasound cavitation therapy (histotripsy) in a porcine model. J Vasc Interv Radiol (2010) 1.30
Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation (2002) 1.30
Patient comprehension of an interactive, computer-based information program for cardiac catheterization: a comparison with standard information. Arch Intern Med (2009) 1.30
Effectiveness of paramedic practitioners in attending 999 calls from elderly people in the community: cluster randomised controlled trial. BMJ (2007) 1.24
Acute type A aortic dissection in the elderly: clinical characteristics, management, and outcomes in the current era. J Am Coll Cardiol (2002) 1.21
Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Arch Intern Med (2010) 1.21
Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel Assay of cardiac markers (RATPAC) trial. Acad Emerg Med (2011) 1.21
Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother (2009) 1.19
Summary of evidence regarding hospital strategies to reduce door-to-balloon times for patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Crit Pathw Cardiol (2007) 1.16
The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions. J Interv Cardiol (2002) 1.16
Characteristics and in-hospital outcomes of patients with cardiac tamponade complicating type A acute aortic dissection. Am J Cardiol (2009) 1.14
Psychological treatment for insomnia in the management of long-term hypnotic drug use: a pragmatic randomised controlled trial. Br J Gen Pract (2003) 1.13
Partnering with payers to improve surgical quality: the Michigan plan. Surgery (2005) 1.12
Improving heart failure self-management support by actively engaging out-of-home caregivers: results of a feasibility study. Congest Heart Fail (2008) 1.12
The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): descriptive analysis from the first 20,000 subjects. Value Health (2005) 1.11
Comparative safety of vascular closure devices. Ann Intern Med (2014) 1.09